Dan V. Iosifescu, M.D.

After receiving his M.D. from the Institute of Medicine and Pharmacy in Bucharest, Romania, Dr. Iosifescu completed an internal medicine internship at Massachusetts General Hospital and a residency in psychiatry at Massachusetts General Hospital and McLean Hospital, serving as Chief Resident in Consultation-Liaison Psychiatry. His research training included a fellowship in neuroimaging in the Neuroscience Laboratory at Harvard Medical School, a fellowship in psychopharmacology in the Mood and Anxiety Disorders Institute at MGH, and a fellowship in the Clinical Investigator Training Program at Harvard/MIT Division of Health Sciences and Technology. In parallel Dr. Iosifescu received a Master of Medical Science (M.M.Sc.) degree from Harvard University.

Dr. Iosifescu is currently Director of Neurophysiology Studies at the Massachusetts General Hospital Depression Clinical and Research Program. His research interests focus on biological markers of treatment outcome in major depressive disorder. In his research Dr. Iosifescu uses neuroimaging (MRI, MRS) and neurophysiology (quantitative EEG) techniques to investigate structural, biochemical, and functional brain abnormalities in mood disorders, and their impact on clinical treatment. Dr. Iosifescu is also interested in the impact of co-morbid medical illness, especially vascular disease, on treatment outcome in mood disorders.

Dr. Iosifescu has authored 20 papers published or in press in peer-reviewed medical journals; he has also published seven book chapters and more than 50 abstracts. Dr. Iosifescu's achievements in clinical research have brought him a series of prestigious prizes: a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD), a Kaplen Research Award and a Livingston Research Award from Harvard Medical School, an American Psychiatric Association Young Investigator Award, an NCDEU New Investigator Award, and a National Institute for Mental Health K23 Career Development Award.